Biora Therapeutics, Inc.
BIOR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $21,294 | $251,348 | $2,009,632 | $2,961,509 |
| - Cash | $15,211 | $30,486 | $88,397 | $92,076 |
| + Debt | $47,426 | $129,305 | $126,404 | $160,541 |
| Enterprise Value | $53,509 | $350,167 | $2,047,639 | $3,029,974 |
| Revenue | $4 | $305 | $1,247 | $74,313 |
| % Growth | -98.7% | -75.5% | -98.3% | – |
| Gross Profit | $4 | $305 | $1,247 | -$19,120 |
| % Margin | 100% | 100% | 100% | -25.7% |
| EBITDA | -$114,054 | -$37,353 | -$164,567 | -$106,181 |
| % Margin | -2,851,350% | -12,246.9% | -13,197% | -142.9% |
| Net Income | -$124,115 | -$38,157 | -$178,521 | -$192,528 |
| % Margin | -3,102,875% | -12,510.5% | -14,316% | -259.1% |
| EPS Diluted | -78.7 | -6.4 | -46.42 | -86.3 |
| % Growth | -1,129.7% | 86.2% | 46.2% | – |
| Operating Cash Flow | -$48,499 | -$64,417 | -$167,486 | -$165,744 |
| Capital Expenditures | -$103 | -$792 | -$855 | -$4,944 |
| Free Cash Flow | -$48,602 | -$65,209 | -$168,341 | -$170,688 |